Literature DB >> 3527754

Protection of mice against Plasmodium berghei infection by a tuftsin derivative.

C M Gupta, A Puri, R K Jain, A Bali, N Anand.   

Abstract

In Plasmodium berghei infections, the mortality rate and parasitaemias were significantly reduced and the mean survival time was considerably enhanced by pretreating the animals with a tuftsin derivative, Thr-Lys-Pro-ARg-NH-(CH2)2-NHCOC15H31. This effect of the modified tuftsin was further increased upon its incorporation in the liposome bilayer. These results indicate that tuftsin and its derivatives may prove useful in enhancing nonspecific host resistance against protozoan infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527754     DOI: 10.1016/0014-5793(86)80927-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice.

Authors:  A Agarwal; H Kandpal; H P Gupta; N B Singh; C M Gupta
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

2.  Respiratory burst in peritoneal exudate cells in response to a modified tuftsin.

Authors:  S P Singh; R Chhabra; V M Srivastava
Journal:  Experientia       Date:  1992-10-15

3.  Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice.

Authors:  Arif Khan; Aijaz A Khan; Varun Dwivedi; Manzoor G Ahmad; Seema Hakeem; Mohammad Owais
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 4.  Liposomes for malaria management: the evolution from 1980 to 2020.

Authors:  Patrick B Memvanga; Christian I Nkanga
Journal:  Malar J       Date:  2021-07-27       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.